Coronavirus Disease 2019 (COVID-19) Impact on Regeneron Pharmaceuticals Inc.

Regeneron is a healthcare company that discovers, develops, manufactures, and markets a wide range of biologic drugs. 


This 32-page PowerPoint based report gives an important expert analysis on how COVID-19 will affect Regeneron. Findings are based on the industry’s most comprehensive platform the Pharma Intelligence Center, including Deals, News, Drugs, Sales, Clinical Trials database and recent analysis.

Reasons to Buy

An overview of how Regeneron will be affected by the COVID-19 pandemic.

Key Players

Regeneron Pharmaceuticals Inc.

Table of Contents

1 Table of Contents (PowerPoint Deck)

1 Executive Summary

2 Company Overview

• Key Stats

• SWOT Analysis

• Sales Overview

3 Regional Analysis

• COVID-19 Spread vs. Location of Regeneron Trials

• COVID-19 vs. Non-COVID-19 Trials

4 Reaction to COVID-19


• Insights Exclusive Intel: Regeneron

• Global Analyst Consensus Sales Forecast

• Upcoming Events

• Disrupted Trials

• Resumed Trials

• Recent Deal Activity

• Recruitment Trends

5 Key Findings

6 Appendix

• Methodology

• About GlobalData

• Contacts


Discounts available for multiple purchases.

+44 20 7947 2960

Join our mailing list

Saved reports